Diagnosing lung cancers through examination of micro-RNA biomarkers in blood, plasma, serum and sputum: a review and summary of current literature

J Gyoba, S Shan, W Roa, ELR Bédard - International journal of molecular …, 2016 - mdpi.com
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …

Applications of microRNAs in the diagnosis and prognosis of lung cancer

J Shen, F Jiang - Expert opinion on medical diagnostics, 2012 - Taylor & Francis
Introduction: Lung cancer is the leading cause of cancer death worldwide, due to its late
diagnosis and poor outcome. MicroRNAs (miRNAs) are small non-coding RNAs that …

[HTML][HTML] MicroRNAs as lung cancer biomarkers

V Del Vescovo, M Grasso, M Barbareschi… - World journal of …, 2014 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer mortality worldwide. Its high mortality is due to
the poor prognosis of the disease caused by a late disease presentation, tumor …

Clinical aspect of microRNA in lung cancer

HC Jeong - Tuberculosis and respiratory diseases, 2014 - synapse.koreamed.org
MicroRNAs (miRNAs) are a class of small noncoding RNAs that modulate target gene
activity, and are aberrantly expressed in most types of cancer as well in lung cancer. A …

[HTML][HTML] miRNAs as non-invasive biomarkers for lung cancer diagnosis

P Ulivi, W Zoli - Molecules, 2014 - mdpi.com
Lung cancer is a leading cause of cancer death and late diagnosis is one of the most
important reasons for the high mortality rate. Circulating microRNAs (miRNAs) represent …

[HTML][HTML] Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

J Shen, NW Todd, H Zhang, L Yu, X Lingxiao… - Laboratory …, 2011 - Elsevier
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related death.
Developing minimally invasive techniques that can diagnose NSCLC, particularly at an early …

[HTML][HTML] Plasma microRNAs as novel biomarkers for early detection of lung cancer

D Zheng, S Haddadin, Y Wang, LQ Gu… - … journal of clinical and …, 2011 - ncbi.nlm.nih.gov
A diagnosis of lung cancer at its early stages is vital for improving the survival rate of
patients. MicroRNAs (miRNAs), a family of 19-to 25-nucleotide non-coding small RNAs, are …

An update on sputum Micro RNA s in lung cancer diagnosis

R Sheervalilou, K Ansarin, S Fekri Aval… - Diagnostic …, 2016 - Wiley Online Library
Lung cancer is one of the leading cause of cancer mortality in the world. It is well known that
genetic damages could result in lung tumor genesis. Despite years of research, the survival …

Early detection of lung cancer in serum by a panel of microRNA biomarkers

P Wang, D Yang, H Zhang, X Wei, T Ma, Z Cheng… - Clinical lung cancer, 2015 - Elsevier
Introduction The objective of the study was to develop a panel of microRNAs (miRNAs) as
highly sensitive and specific biomarkers for lung cancer early detection. Materials and …

[HTML][HTML] Identification of a panel of serum microRNAs as biomarkers for early detection of lung adenocarcinoma

S Lv, J Xue, C Wu, L Wang, J Wu, S Xu, X Liang… - Journal of …, 2017 - ncbi.nlm.nih.gov
Introduction: Since currently no sensitive and specific biomarkers for early detection of lung
adenocarcinoma (AD) exist and the majority of AD patients are diagnosed at late stages of …